-
Loading metrics
Open Access
Peer-reviewed
Research Article
Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML)
-
Melanie Gentil,
Roles Investigation
Affiliations Inserm U935, Villejuif, France, University Paris Sud, Faculty of Medicine, Le Kremlin Bicêtre, France
⨯ -
Patricia Hugues,
Roles Investigation
Affiliations Inserm U935, Villejuif, France, University Paris Sud, Faculty of Medicine, Le Kremlin Bicêtre, France, Service d’Hématologie, Hôpital Bicêtre and Paul Brousse, Le Kremlin Bicêtre and Villejuif, France
⨯ -
Christophe Desterke,
Roles Formal analysis, Methodology, Validation, Writing – original draft
Affiliations Inserm U935, Villejuif, France, University Paris Sud, Faculty of Medicine, Le Kremlin Bicêtre, France
⨯ -
Gladys Telliam,
Roles Investigation
Affiliations Inserm U935, Villejuif, France, University Paris Sud, Faculty of Medicine, Le Kremlin Bicêtre, France
⨯ -
Ivan Sloma,
Roles Investigation
Affiliations Inserm U935, Villejuif, France, University Paris Sud, Faculty of Medicine, Le Kremlin Bicêtre, France, Service d’Hématologie, Hôpital Bicêtre and Paul Brousse, Le Kremlin Bicêtre and Villejuif, France
⨯ - Lucas E. B. Souza,
-
Seda Baykal,
Roles Investigation
Affiliations Inserm U935, Villejuif, France, Dokuz Eylul University Medical School, Medical Biology and Genetics Dept, Izmir, Turkey
⨯ -
Jerome Artus,
Roles Investigation, Writing – review & editing
Affiliations Inserm U935, Villejuif, France, University Paris Sud, Faculty of Medicine, Le Kremlin Bicêtre, France
⨯ - Frank Griscelli,
- Agnes Guerci,
- Hyacinthe Johnson-Ansah,
- Adlen Foudi,
-
Annelise Bennaceur-Griscelli,
Roles Funding acquisition, Supervision, Writing – review & editing
Affiliations Inserm U935, Villejuif, France, University Paris Sud, Faculty of Medicine, Le Kremlin Bicêtre, France, Service d’Hématologie, Hôpital Bicêtre and Paul Brousse, Le Kremlin Bicêtre and Villejuif, France, Institut Federatif d’Hématologie Paris Sud (IFHIPS), APHP and Service d’Hématologie Bicêtre and Paul Brousse, Villejuif, France
⨯ -
Ali G. Turhan
Roles Conceptualization, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Validation, Writing – original draft
* E-mail: turviv33@gmail.com
Affiliations Inserm U935, Villejuif, France, University Paris Sud, Faculty of Medicine, Le Kremlin Bicêtre, France, Service d’Hématologie, Hôpital Bicêtre and Paul Brousse, Le Kremlin Bicêtre and Villejuif, France, Institut Federatif d’Hématologie Paris Sud (IFHIPS), APHP and Service d’Hématologie Bicêtre and Paul Brousse, Villejuif, France
⨯
Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML)
- Melanie Gentil,
- Patricia Hugues,
- Christophe Desterke,
- Gladys Telliam,
- Ivan Sloma,
- Lucas E. B. Souza,
- Seda Baykal,
- Jerome Artus,
- Frank Griscelli,
- Agnes Guerci
- Published: August 9, 2018
- https://doi.org/10.1371/journal.pone.0200923